中华医院管理杂志
中華醫院管理雜誌
중화의원관리잡지
CHINESE JOURNAL OF HOSPITAL ADMINISTRATION
2013年
10期
745-749
,共5页
贾慧珣%谢静%吴毓%袁晶%朱骥%郭小毛
賈慧珣%謝靜%吳毓%袁晶%硃驥%郭小毛
가혜순%사정%오육%원정%주기%곽소모
临床路径%诊疗费用%大肠癌
臨床路徑%診療費用%大腸癌
림상로경%진료비용%대장암
Clinical pathway%Medical expenses%Colorectal cancer
目的 在临床路径的基础上,探讨影响大肠癌医保患者诊疗费用的主要因素,并根据影响因素对其临床路径进行优化,以降低大肠癌诊疗的医疗费用.方法 选择复旦大学附属肿瘤医院2009至2010年2年间出院的大肠癌医保患者作为研究对象,共计467人.应用逐步多元线性回归分析的方法,筛选和确定影响诊疗费用的关键因素;将现有的临床路径进行优化,并对优化前后的诊疗费用进行比较.结果 发现住院天数、有无并发症合并症是影响大肠癌医保患者总的诊疗费用的关键因素;而临床路径的优化均能不同程度地降低大肠癌的诊疗费用.结论 主要结果可为医院大肠癌单病种付费提供依据,同时为医保基金的支付提供参考,对切实减轻患者经济负担具有重要的现实意义.
目的 在臨床路徑的基礎上,探討影響大腸癌醫保患者診療費用的主要因素,併根據影響因素對其臨床路徑進行優化,以降低大腸癌診療的醫療費用.方法 選擇複旦大學附屬腫瘤醫院2009至2010年2年間齣院的大腸癌醫保患者作為研究對象,共計467人.應用逐步多元線性迴歸分析的方法,篩選和確定影響診療費用的關鍵因素;將現有的臨床路徑進行優化,併對優化前後的診療費用進行比較.結果 髮現住院天數、有無併髮癥閤併癥是影響大腸癌醫保患者總的診療費用的關鍵因素;而臨床路徑的優化均能不同程度地降低大腸癌的診療費用.結論 主要結果可為醫院大腸癌單病種付費提供依據,同時為醫保基金的支付提供參攷,對切實減輕患者經濟負擔具有重要的現實意義.
목적 재림상로경적기출상,탐토영향대장암의보환자진료비용적주요인소,병근거영향인소대기림상로경진행우화,이강저대장암진료적의료비용.방법 선택복단대학부속종류의원2009지2010년2년간출원적대장암의보환자작위연구대상,공계467인.응용축보다원선성회귀분석적방법,사선화학정영향진료비용적관건인소;장현유적림상로경진행우화,병대우화전후적진료비용진행비교.결과 발현주원천수、유무병발증합병증시영향대장암의보환자총적진료비용적관건인소;이림상로경적우화균능불동정도지강저대장암적진료비용.결론 주요결과가위의원대장암단병충부비제공의거,동시위의보기금적지부제공삼고,대절실감경환자경제부담구유중요적현실의의.
Objective To explore the main factors affecting medical expenses of patients with colorectal cancer(CRC)and reduce such expenses by optimizing the clinical pathway of CRC according to the influencing factors.Methods Data of 467 discharged and medical insured CRC patients at Shanghai Cancer Center,Fudan University,were collected from 2009 to 2010.A multiple linear regression model was applied to analyze the influencing factors of medical expenses.The clinical pathway of CRC was optimized,and medical expenses before and after optimization were compared.Results Our data found days of stay and complications had impact on the medical expenses.Also,medical expenses were decreased accordingly with optimization of clinical pathway of CRC.Conclusion This study provides evidence for decision-making on single disease payment and medical insurance compensation on CRC.It is also meaningful to reduce the economic burden of patients with CRC.